Form 8-K - Current report:
SEC Accession No. 0001193125-13-010725
Filing Date
2013-01-11
Accepted
2013-01-11 16:02:39
Documents
1
Period of Report
2013-01-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d462434d8k.htm 8-K 20192
  Complete submission text file 0001193125-13-010725.txt   21195
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 13525531
SIC: 2834 Pharmaceutical Preparations